Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03681262 · ClinicalTrials.gov registry record · NA

Comparing Long-term Effectiveness of High Frequency and Burst Spinal Cord Stimulation

A NA study of Chronic Pain, sponsored by Stanford University.

Active
Registry status
NA
Development phase
7
Enrollment target
1
Study location

NCT03681262: Active NA study of Chronic Pain, sponsored by Stanford University.

NCT03681262 is a NA study of Chronic Pain that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 7 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03681262, a NA study of Chronic Pain, is active but no longer recruiting, sponsored by Stanford University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
7 participants
Enrollment target
1
Study location

Study Summary

Over 100 million Americans suffer from chronic pain resulting in annual cost of roughly $635 billion. Limited treatments are available for this widespread disease. The data supporting these treatments lack generalizability to patients with more serious medical and psychological comorbidities who are often excluded from explanatory efficacy trials. This study aims to integrate randomized comparative effectiveness research with patient care. The investigators will randomize the patients and collect data using an open-source learning healthcare system already in use in the department to monitor patients' progress: Collaborative Health Outcomes Information Registry (CHOIR). CHOIR uses the National Institute of Health Patient Reported Outcomes Measurement Information System item banks for comparative metrics through computer adaptive testing. The investigators will leverage the advantage of this novel system to compare effectiveness of high frequency and burst spinal cord stimulation in improving pain and function in patients with chronic back and/or leg pain. Spinal cord stimulation is an effective treatment for chronic pain resulting in \>50% pain relief in about half of the patients. Novel waveforms for spinal cord stimulation - high frequency and burst - increased the efficacy of this treatment even further. However, there is lack of data guiding decision making of the clinicians in choosing the best waveform in treating the patients with chronic pain. The proposed study will provide the clinicians with this evidence. Currently, data about safety and efficacy of these two novel waveforms is available for up to 24 months. The proposed research will provide data about effectiveness of these two modalities for at least 36 months. Moreover, this study will evaluate feasibility of integrating randomized comparative effectiveness research with patient care in Stanford Pain Management subspecialty clinic. CHOIR can then be applied for numerous future trials to advance knowl

Primary Outcome

Change from baseline in pain intensity at 12 months. Baseline pain intensity is measured at last CHOIR completion before trial, and is based on patient reported outcome in CHOIR for average pain in the week prior to completion of questionnaire. Score range: 0-10 (higher scores correspond to more severe pain)

Conditions Studied

Interventions

  • DEVICE High frequency spinal cord stimulation
  • DEVICE Burst spinal cord stimulation

Study Locations (1)

California

  • Stanford Pain Management Center - Redwood City

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2019-08-01
Est. Completion 2026-12-31
Phase NA
Stanford University

1,744 total trials

What the registry record for NCT03681262 still lists

NCT03681262 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which High frequency spinal cord stimulation is the first listed.

NCT03681262 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03681262 about?

NCT03681262 is a clinical study titled "Comparing Long-term Effectiveness of High Frequency and Burst Spinal Cord Stimulation". Over 100 million Americans suffer from chronic pain resulting in annual cost of roughly $635 billion. Limited treatments are available for this widespread disease. The data supporting these treatments lack generalizability to patients with more serious medical and psychological comorbidities who are...

What is the current status of trial NCT03681262?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 7 participants. The study started on 2019-08-01. Estimated completion is 2026-12-31.

What conditions does trial NCT03681262 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT03681262?

The interventions under investigation include: High frequency spinal cord stimulation (DEVICE), Burst spinal cord stimulation (DEVICE).

Who is sponsoring clinical trial NCT03681262?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03681262 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03681262's enrollment target sits among peer trials

7 300th of 301 higher than 2 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03681262, the US trial registry maintained by the National Library of Medicine. NCT03681262 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.